HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Helen of Troy Q1

This article was originally published in The Rose Sheet

Executive Summary

Firm posts 11.3% increase in revenue to $160.2 mil. and profit jump of 27% to $18.4 mil. in first fiscal 2010 quarter ended May 31, attributed to recent acquisitions of Infusium 23, Pert Plus and Sure (1"The Rose Sheet" March 15, 2010, In Brief). El Paso, Texas firm recorded revenue of $112.2 in its personal-care segment, up nearly 11% from the same quarter a year ago. Helen of Troy plans integration and development of new Pert Plus and Sure product lines in this fiscal year while pursuing "additional acquisitions of complementary businesses or product lines," according to July 8 release

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017052

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel